Softgel Capsules Market Size, Share, Trends, Industry Analysis Report: By Type, Application, End Use, and Region

Description

List of Tables

The global softgel capsules market size is expected to reach USD 16.75 billion by 2034, according to a new study by Polaris Market Research. The report "Softgel Capsules Market Size, Share, Trends, Industry Analysis Report: By Type (Gelatin-Based/Animal-Based and Non-Animal-Based), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The softgel capsules market encompasses the production, distribution, and consumption of encapsulated dosage forms featuring a soft, pliable outer shell, typically made from gelatin or vegetarian alternatives, containing liquid or semi-solid fill materials. These capsules serve as a preferred delivery method for pharmaceuticals, nutraceuticals, and cosmeceuticals, offering advantages such as ease of swallowing, improved bioavailability, and the ability to mask unpleasant tastes or odors. The market is characterized by a diverse range of applications, catering to various therapeutic areas and consumer health needs.

An overview of the market reveals a dynamic landscape driven by increasing consumer awareness of preventive healthcare, technological advancements in encapsulation, and the growing geriatric population. The rising demand for dietary supplements, coupled with the pharmaceutical industry's focus on enhancing drug delivery systems, is propelling market expansion. Key softgel capsules market trends include the adoption of vegetarian softgels, customized formulations, and the expansion of contract manufacturing organizations. The market is also influenced by stringent regulatory standards and the need for high-quality, reliable softgel solutions, shaping the competitive environment and driving innovation.

Softgel Capsules Market Report Highlights

By type, the gelatin-based/animal-based softgels segment holds a larger softgel capsules market share due to their long-established use and cost-effectiveness in pharmaceutical and nutraceutical applications. This dominance is supported by well-established manufacturing infrastructures and regulatory frameworks.

By application, the vitamin & dietary supplement segment commands the largest market share, driven by widespread consumer adoption for preventative health and wellness. The ease of consumption and perceived efficacy of softgel capsules in delivering these supplements contribute to their sustained market dominance.

By end use, the pharmaceutical companies segment holds the largest market share, driven by the extensive use of softgel capsules for drug delivery across various therapeutic areas. Their established manufacturing infrastructure and rigorous quality control processes ensure the production of high-quality softgel capsules.

By region, North America currently holds the largest market share, characterized by a robust pharmaceutical industry and high consumer adoption of dietary supplements. The Asia Pacific market is experiencing the highest growth rate, driven by a rapidly expanding healthcare sector and increasing disposable incomes.

Key players active in the softgel capsules market include Catalent, Inc.; Lonza Group AG; Robinson Pharma, Inc.; Captek Softgel International, Inc.; Sirio Pharma Co., Ltd.; Softigel (Procaps Group S.A.); Aenova Holding GmbH; and EuroCaps Ltd.

Polaris Market Research has segmented the market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue-USD Billion, 2020-2034)

Gelatin-Based/Animal-Based

Non-Animal-Based

By Application Outlook (Revenue-USD Billion, 2020-2034)

Antacid & Anti-Flatulent Preparation

Anti-Anemic Preparations

Anti-Inflammatory Drugs

Antibiotic & Antibacterial Drugs

Cough & Cold Preparations

Health Supplement

Vitamin & Dietary Supplement

Pregnancy

By End Use Outlook (Revenue-USD Billion, 2020-2034)

Pharmaceutical Companies

Nutraceutical Companies

Cosmeceutical Companies

Contract Manufacturing Organizations

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of the Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM2200

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Softgel Capsules Market Insights

4.1. Softgel Capsules Market - Market Snapshot
4.2. Softgel Capsules Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Demand for Dietary Supplements and Nutraceuticals
  - 4.2.1.2. Enhanced Bioavailability and Drug Delivery
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Gelatin source concerns
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Softgel Capsules Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Softgel Capsules Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
5.3. Gelatin-Based/Animal-Based
- 5.3.1. Global Softgel Capsules Market, by Gelatin-Based/Animal-Based, by Region, 2020-2034 (USD Billion)
5.4. Non-Animal-Based
- 5.4.1. Global Softgel Capsules Market, by Non-Animal-Based, by Region, 2020-2034 (USD Billion)

6. Global Softgel Capsules Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
6.3. Antacid & Anti-Flatulent Preparation
- 6.3.1. Global Softgel Capsules Market, by Antacid & Anti-Flatulent Preparation, by Region, 2020-2034 (USD Billion)
6.4. Anti-Anemic Preparations
- 6.4.1. Global Softgel Capsules Market, by Anti-Anemic Preparations, by Region, 2020-2034 (USD Billion)
6.5. Anti-Inflammatory Drugs
- 6.5.1. Global Softgel Capsules Market, by Anti-Inflammatory Drugs, by Region, 2020-2034 (USD Billion)
6.6. Antibiotic & Antibacterial Drugs
- 6.6.1. Global Softgel Capsules Market, by Antibiotic & Antibacterial Drugs, by Region, 2020-2034 (USD Billion)
6.7. Cough & Cold Preparations
- 6.7.1. Global Softgel Capsules Market, by Cough & Cold Preparations, by Region, 2020-2034 (USD Billion)
6.8. Health Supplement
- 6.8.1. Global Softgel Capsules Market, by Health Supplement, by Region, 2020-2034 (USD Billion)
6.9. Vitamin & Dietary Supplement
- 6.9.1. Global Softgel Capsules Market, by Vitamin & Dietary Supplement, by Region, 2020-2034 (USD Billion)
6.10. Pregnancy
- 6.10.1. Global Softgel Capsules Market, by Pregnancy, by Region, 2020-2034 (USD Billion)

7. Global Softgel Capsules Market, by End-Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
7.3. Pharmaceutical Companies
- 7.3.1. Global Softgel Capsules Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
7.4. Nutraceutical Companies
- 7.4.1. Global Softgel Capsules Market, by Nutraceutical Companies, by Region, 2020-2034 (USD Billion)
7.5. Cosmeceutical Companies
- 7.5.1. Global Softgel Capsules Market, by Cosmeceutical Companies, by Region, 2020-2034 (USD Billion)
7.6. Contract Manufacturing Organizations
- 7.6.1. Global Softgel Capsules Market, by Contract Manufacturing Organizations, by Region, 2020-2034 (USD Billion)

8. Global Softgel Capsules Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Softgel Capsules Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Softgel Capsules Market - North America
- 8.3.1. North America: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.3.4. Softgel Capsules Market - U.S.
  - 8.3.4.1. U.S.: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.3.5. Softgel Capsules Market - Canada
  - 8.3.5.1. Canada: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
8.4. Softgel Capsules Market - Europe
- 8.4.1. Europe: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.4.4. Softgel Capsules Market - UK
  - 8.4.4.1. UK: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.4.5. Softgel Capsules Market - France
  - 8.4.5.1. France: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.4.6. Softgel Capsules Market - Germany
  - 8.4.6.1. Germany: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.4.7. Softgel Capsules Market - Italy
  - 8.4.7.1. Italy: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.4.8. Softgel Capsules Market - Spain
  - 8.4.8.1. Spain: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.4.9. Softgel Capsules Market - Netherlands
  - 8.4.9.1. Netherlands: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.4.10. Softgel Capsules Market - Russia
  - 8.4.10.1. Russia: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.4.11. Softgel Capsules Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
8.5. Softgel Capsules Market - Asia Pacific
- 8.5.1. Asia Pacific: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.5.4. Softgel Capsules Market - China
  - 8.5.4.1. China: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.5.5. Softgel Capsules Market - India
  - 8.5.5.1. India: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.5.6. Softgel Capsules Market - Malaysia
  - 8.5.6.1. Malaysia: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.5.7. Softgel Capsules Market - Japan
  - 8.5.7.1. Japan: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.5.8. Softgel Capsules Market - Indonesia
  - 8.5.8.1. Indonesia: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.5.9. Softgel Capsules Market - South Korea
  - 8.5.9.1. South Korea: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.5.10. Softgel Capsules Market - Australia
  - 8.5.10.1. Australia: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.5.11. Softgel Capsules Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
8.6. Softgel Capsules Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.6.4. Softgel Capsules Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.6.5. Softgel Capsules Market - UAE
  - 8.6.5.1. UAE: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.6.6. Softgel Capsules Market - Israel
  - 8.6.6.1. Israel: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.6.7. Softgel Capsules Market - South Africa
  - 8.6.7.1. South Africa: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.6.8. Softgel Capsules Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
8.7. Softgel Capsules Market - Latin America
- 8.7.1. Latin America: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.7.4. Softgel Capsules Market - Mexico
  - 8.7.4.1. Mexico: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.7.5. Softgel Capsules Market - Brazil
  - 8.7.5.1. Brazil: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.7.6. Softgel Capsules Market - Argentina
  - 8.7.6.1. Argentina: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)
- 8.7.7. Softgel Capsules Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Softgel Capsules Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Softgel Capsules Market, by Application, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Softgel Capsules Market, by End-Use, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Aenova Holding GmbH
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Captek Softgel International, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Catalent, Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. EuroCaps Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Lonza Group AG
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Robinson Pharma, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Sirio Pharma Co., Ltd.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Softigel (Procaps Group S.A.)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development